Pharmacokinetics and Safety of Nelfinavir When Used in Combination with Zidovudine and Lamivudine in HIV-Infected Pregnant Women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353
Yvonne J. Bryson(Oklahoma State University Center for Health Sciences), Yohannes G. Asfaw, Sharon Huang(FuelCell Energy (United States)), Edmund V. Capparelli(University of California San Diego), Elizabeth Smith(National Jewish Health), Michael A. Keller(American Red Cross), D. Heather Watts(National Institutes of Health), Kathleen A. Kaiser(Frontier Science & Technology Research Foundation), Lynette Purdue(National Institutes of Health), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Michael D. Hughes(Virginia Tech), Alice Stek(University of Southern California), James D. Connor, Mark Mirochnick(Boston University)
Cited by 48
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697
Measles Antibody: Reevaluation of Protective Titers
|The Journal of Infectious Diseases|1990|612